Onya Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Later Stage VC
  • (In Progress)

  • Latest Deal Amount
  • $13.4M

  • Investors
  • 7

Onya Therapeutics General Information

Description

Developer of a medicated patch designed to transform passive wound care into active wound healing. The company offers a patented patch with targeted therapeutic delivery, enabling patients with chronic and acute wounds to experience improved healing outcomes and reduced care burden.

Contact Information

Website
www.onya.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The Innovation Centre
  • Victoria Business Park
  • Ebbw Vale NP23 8XA
  • Wales, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • The Innovation Centre
  • Victoria Business Park
  • Ebbw Vale NP23 8XA
  • Wales, United Kingdom

Onya Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Onya Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 01-May-2026 $13.4M In Progress Clinical Trials - Phase 2
6. Later Stage VC 11-Feb-2026 Completed Pre-Clinical Trials
5. Seed Round 03-Oct-2025 Completed Generating Revenue
4. Seed Round 06-Aug-2024 Completed Generating Revenue
3. Angel (individual) 31-Jan-2024 Completed Pre-Clinical Trials
2. Corporate 01-Jan-2021 $1.34M $1.34M Completed Generating Revenue
1. Spin-Off 05-Feb-2020 Completed Pre-Clinical Trials
To view Onya Therapeutics’s complete valuation and funding history, request access »

Onya Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A1 shares
Ordinary
Ordinary 1,150,905 $0.000003 $0.27 $0.27 1x $0.27 32.4%
To view Onya Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Onya Therapeutics Patents

Onya Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017332832-A1 Patch comprising potassium permanganate for the treatment of skin disorder Active 23-Sep-2016
AU-2017332832-B2 Patch comprising potassium permanganate for the treatment of skin disorder Active 23-Sep-2016
CA-3037807-A1 Patch comprising potassium permanganate for the treatment of skin disorder Active 23-Sep-2016
EP-3515416-A1 Patch comprising potassium permanganate for the treatment of skin disorder Active 23-Sep-2016
EP-3515416-B1 Patch comprising potassium permanganate for the treatment of skin disorder Active 23-Sep-2016 A61K9/7007
To view Onya Therapeutics’s complete patent history, request access »

Onya Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Onya Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Angel (individual) Minority
Bionexus (Pharmaceuticals and Biotechnology) Corporation Minority
South East Angels Angel Group Minority
Angel (individual) Minority
You’re viewing 5 of 7 investors. Get the full list »

Onya Therapeutics FAQs

  • When was Onya Therapeutics founded?

    Onya Therapeutics was founded in 2020.

  • Where is Onya Therapeutics headquartered?

    Onya Therapeutics is headquartered in Ebbw Vale, United Kingdom.

  • What is the size of Onya Therapeutics?

    Onya Therapeutics has 11 total employees.

  • What industry is Onya Therapeutics in?

    Onya Therapeutics’s primary industry is Drug Discovery.

  • Is Onya Therapeutics a private or public company?

    Onya Therapeutics is a Private company.

  • What is the current valuation of Onya Therapeutics?

    The current valuation of Onya Therapeutics is .

  • What is Onya Therapeutics’s current revenue?

    The current revenue for Onya Therapeutics is .

  • How much funding has Onya Therapeutics raised over time?

    Onya Therapeutics has raised $8.14M.

  • Who are Onya Therapeutics’s investors?

    , , Bionexus (Pharmaceuticals and Biotechnology), South East Angels, and are 5 of 7 investors who have invested in Onya Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process